Establishment of a model to assess mumps virus neurovirulence in neonatal Wistar rats

Juncheng Ruan1, Wanyu Dong2, Yuanbao Liu3

  • 1R&D Department, Shanghai King-cell Biotechnology Co., Ltd., Shanghai 201506, China.

Vaccine
|October 2, 2022
PubMed

Insights

A new vibratome sectioning method efficiently evaluates mumps virus (MuV) neurovirulence in neonatal rats. This improved technique offers a more objective and repeatable assessment for mumps vaccine development.

Area of Science:

  • Virology
  • Neuroscience
  • Vaccine Development

Background:

  • Mumps virus (MuV) exhibits high neurotropism and neurovirulence, necessitating rigorous testing of vaccine seed strains.
  • Traditional neurovirulence evaluation using paraffin sectioning and HE staining is time-consuming and complex.

Purpose of the Study:

  • To develop a more efficient and objective method for evaluating MuV neurovirulence.
  • To establish a sensitive and repeatable neonatal rat model for MuV neurovirulence assessment.

Main Methods:

  • Deployment of a vibratome sectioning system as an alternative to paraffin sectioning for MuV neurovirulence evaluation in rat brains.
  • Investigation of varying MuV doses and neonatal rat ages (in days) to optimize the evaluation method.

Main Results:

  • The vibratome sectioning method demonstrated objective and efficient assessment of MuV neurovirulence potential.
  • MuV doses of at least 105 50% cell culture infective doses (CCID50) induced significant cavity formation in 1-day-old rat brains.
  • The developed neonatal rat model exhibited high sensitivity and good repeatability for evaluating different MuV strains.

Conclusions:

  • Vibratome sectioning provides a superior alternative for MuV neurovirulence assessment compared to traditional methods.
  • The optimized neonatal rat model is suitable for sensitive and repeatable evaluation of mumps virus neurovirulence, supporting vaccine safety.

Related Concept Videos